List view / Grid view
7 October 2025 | By Rapid Micro Biosystems
This webinar showcases a rapid microbial method that can help to address the time to result challenge posed by short shelf-life radiopharmaceuticals.
The innovative approach facilitates QSRR-assisted chromatographic development for N-nitrosamine analysis in pharmaceutical products.
The right packaging is critical when it comes to preserving the quality, efficacy and safety of pharmaceutical and nutraceutical products. Here, Uwe Raupbach, R&D Engineer Desiccants, Sanner GmbH, answers some key questions about the need for environmental management in packaging, focusing on moisture and odour control, and the solutions available…
This in-depth focus features articles on rapid microbiological methods, quality control, and using AI to read agar plates.
This in-depth focus features articles on cell and gene therapy in Europe and enhancing drug delivery with cost-effective solutions.
In this Guide to Outsourcing article, Doug Botkin, PhD Scientific Portfolio Specialist from Charles River Laboratories, examines how modern microbial ID tools can enhance contamination control strategies and explores the benefits an outsourcing partner can provide.
EPR Issue 3 includes articles on microbiology, downstream processing, manufacturing, drug formulation and more.
Winners of this year's awards will be revealed during the opening of CPHI Frankfurt 2025.
The ICH Assembly’s decision supports progress in promoting international standards for safety assessment of medicines.
The novel approach could enhance quality testing applications in pharmaceutical manufacturing.
2 September 2025 | By FUJIFILM Wako Europe GmbH
Join this webinar to find out how RT-rt PCR is revolutionising sterility testing and discover a unique approach that provides reliable one-day results and enhanced sensitivity and detection capabilities.
The University of Cambridge and A*STAR platform aims to enhance fault detection, system monitoring and predictive maintenance.
Revisions to the harmonised general chapter “Particulate Contamination (Q-09)” aim to improve pharmaceutical drug development.
US regulator says the move to open up the FAERS database will help modernise its safety monitoring.
Draft publication is set to expand its frameworks for new medicinal products, including cell and gene therapies.
